Insights

Insights

Filter by:
Governing Laws
Sector Life sciences & healthcare
Sub-sector
Service
Sub-service
Hot Topics Coronavirus
black-robotic-arm
Synapse

COVID-19 postponement of MDR implementation date – how does this fit with Brexit?

26 May 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi

Click here to find out more
server-room
Coronavirus

What you need to know about the UK Government's new Future Fund 2.0

19 May 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
Environmental, planning & regulatory

Hope for compensation for Corona-related plant closures increases

15 May 2020

by Karolina Lange, LL.M. (Medizinrecht) and Juliane Dost

Click here to find out more
Life sciences & healthcare

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29 April 2020

by multiple authors

Click here to find out more
colourful-tech
Coronavirus

What you need to know about the UK government's new Future Fund

27 April 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
blueprints
Synapse

Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?

22 April 2020
IN-DEPTH ANALYSIS

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

Click here to find out more
Life sciences & healthcare

Termination, force majeure and frustration – international perspectives on the life sciences sector

17 April 2020
QUICK READ

by multiple authors

Click here to find out more
petri dishes
Patents & innovation

COVID-19 and public compulsory licensing of drugs in Europe

17 April 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
pipette
Synapse

COVID-19 and life sciences M&A

16 April 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
Patents & innovation

Marketing authorisation and clinical testing of new drugs

15 April 2020

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

Click here to find out more
Patents & innovation

Restrictions for patents owners to preserve the public interest in the sufficient availability of necessary medicinal products

7 April 2020

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

Click here to find out more
scientist
Synapse

COVID-19: healthcare and law

31 March 2020
IN-DEPTH ANALYSIS

by JUDr Barbora Dubanská and Patrick Boháček

Click here to find out more